Tam, C.S. Opat, S. D'Sa, S. Jurczak, W. Lee, H.-P. Cull, G. Owen, R.G. Marlton, P. Ewahlin, B. Sanz, R.G. McCarthy, H. Mulligan, S. Tedeschi, A. Castillo, J.J. Czyz, J. De Larrea, C.F. Belada, D. Libby, E. Matous, J.V. Motta, M. Siddiqi, T. Tani, M. Trneny, M. Minnema, M.C. Buske, C. Leblond, V. Trotman, J. Chan, W.Y. Schneider, J. Ro, S. Cohen, A. Huang, J., A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study, Blood advances, (136), 2038-2050, 2020, American Society of Hematology,